Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 80,953 | 77,765 | 78,512 | 75,588 | 60,400 |
| Marketable Securities | 30,105 | 25,383 | 21,849 | 24,356 | 27,070 |
| Receivables | 30,717 | 42,961 | 40,440 | 40,715 | 45,358 |
| Inventories | 25,143 | 23,228 | 25,657 | 27,125 | 28,670 |
| Income taxes - deferred | 4,708 | 4,355 | 4,164 | 3,954 | 4,073 |
| Other current assets | 0 | 493 | 432 | 458 | 0 |
| TOTAL | $180,464 | $183,175 | $179,806 | $181,648 | $174,515 |
| Non-Current Assets | |||||
| PPE Net | 166,746 | 169,559 | 171,400 | 169,973 | 167,502 |
| Investments And Advances | 956 | 956 | 956 | 956 | 956 |
| Intangibles | 20,012 | 42,800 | 42,180 | 40,137 | 42,290 |
| Other Non-Current Assets | 5,514 | 3,243 | 4,452 | 5,140 | 5,421 |
| TOTAL | $193,228 | $216,558 | $218,988 | $216,206 | $216,169 |
| Total Assets | $373,692 | $399,733 | $398,794 | $397,854 | $390,684 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 270 | 270 | 270 | 260 | 260 |
| Accounts payable and accrued liabilities | 15,277 | 19,820 | 21,147 | 22,722 | 16,480 |
| Accrued Expenses | 3,309 | 145 | 500 | 500 | 6,584 |
| TOTAL | $30,734 | $32,863 | $33,212 | $38,892 | $33,822 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,212 | 13,212 | 13,212 | 13,482 | 13,482 |
| Deferred Revenues | 10,777 | 10,728 | 9,768 | 8,632 | 7,300 |
| Other Non-Current Liabilities | 6,636 | 6,741 | 6,375 | 6,389 | 6,402 |
| TOTAL | $28,345 | $33,928 | $34,845 | $34,585 | $30,182 |
| Total Liabilities | $59,079 | $66,791 | $68,057 | $73,477 | $64,004 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,673 | 31,644 | 31,659 | 31,631 | 31,490 |
| Common Shares | 355 | 355 | 355 | 355 | 353 |
| Retained earnings | 174,121 | 193,302 | 192,937 | 192,758 | 190,816 |
| Other shareholders' equity | -4,530 | -4,806 | -5,895 | -11,471 | -6,509 |
| TOTAL | $314,613 | $332,942 | $330,737 | $324,377 | $326,680 |
| Total Liabilities And Equity | $373,692 | $399,733 | $398,794 | $397,854 | $390,684 |